BioSpace News Archive

CVS Health (NYSE: CVS) today announced that MinuteClinic, the company’s retail medical clinic, has rolled out its new virtual health care offering in the state of New Mexico

Time-to-market and omni-channel are keywords when it comes to competing in today’s rapidly evolving marketplace.

Univfy, a machine learning and predictive analytics company with a mission to expand in vitro fertilization access and affordability, today announced that Dr. Mylene Yao, Co-founder and CEO, will present at the Digital Medicine & Medtech Showcase 2019, held on January 7-9, 2019 at the Parc 55 San Francisco Hilton Hotel in Union Square.

ArTara Therapeuticss, a clinical-stage company developing treatments for rare diseases with significant unmet needs, today announced that it has successfully completed an End-of-Phase 2 meeting with the Food and Drug Administration (FDA) to discuss study of Intravenous (IV) Choline Chloride substrate replacement for patients with Intestinal Failure Associated Liver Disease (IFALD).

Monteris Medical, the leader in image-guided laser interstitial thermotherapy (LITT), is pleased to announce that health insurance provider Anthem, Inc. has established Clinical Utilization Management (UM) Guidelines for LITT allowing access to a minimally invasive surgical option to its beneficiaries with refractory epilepsy when the established medical necessity criteria have been met.

Findings establish “New normal” for when children reach full height

Gallagher’s 2018 Benefits Strategy & Benchmarking Survey – Canada Edition shows how more than 450 employers are leveraging benefit offerings to attract and retain talent

Glenmark’s branded portfolio for the US market will be developed and commercialized by Glenmark Therapeutics Inc., USA, a wholly owned subsidiary of Glenmark Holding, SA

Prime Therapeutics LLC (Prime), will continue its National Committee for Quality Assurance (NCQA) programs in two areas: 1) Health Information Products (HIP) – Pharmacy Benefit Information and 2) Utilization Management.

AGC has announced a major enhancement to its production capacity of biopharmaceutical manufacturing services at AGC Biologics (Headquarters: US), a CDMO*1 subsidiary of the company.